Fowsiyo Ahmed
Overview
Explore the profile of Fowsiyo Ahmed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antwi S, Heckman M, White L, Yan I, Sarangi V, Lauer K, et al.
Hum Mol Genet
. 2023 Jun;
32(16):2646-2655.
PMID: 37369012
Animal studies implicate one-carbon metabolism and DNA methylation genes in hepatocellular carcinoma (HCC) development in the setting of metabolic perturbations. Using human samples, we investigated the associations between common and...
2.
Mohamed E, Giama N, Abdalla A, Shaleh H, Oseini A, Ali H, et al.
World J Gastroenterol
. 2022 Oct;
28(35):5217-5229.
PMID: 36188718
Background: Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are known risk factors for liver disease, cirrhosis and hepatocellular carcinoma (HCC). There is substantial global variation in...
3.
Clarke-Brodber A, Hartley C, Ahmed F, Thangaiah J, Tiegs-Heiden C, Hagen C
Ann Diagn Pathol
. 2022 Jul;
60:152015.
PMID: 35908332
Desmoid-type fibromatosis (desmoid tumors) which involve the pancreas is an infrequent diagnosis which clinically can mimic both neoplastic and non-neoplastic lesions of the pancreas. The cytologic features of loosely cohesive...
4.
Wang H, Hou W, Perera A, Bettler C, Beach J, Ding X, et al.
Cell Rep
. 2021 Feb;
34(8):108765.
PMID: 33626345
Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide. One major obstacle to treatment is a lack of effective molecular-targeted therapies. In this study, we find that EphA2 expression...
5.
Hlady R, Zhao X, Pan X, Yang J, Ahmed F, Antwi S, et al.
Theranostics
. 2019 Nov;
9(24):7239-7250.
PMID: 31695765
Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is growing in incidence but treatment options remain limited, particularly for late stage disease. As liver cirrhosis is the principal...
6.
Yang J, Ahmed F, Mara K, Addissie B, Allen A, Gores G, et al.
Hepatology
. 2019 Jul;
71(3):907-916.
PMID: 31309602
Diabetes increases the risk of liver disease progression and cirrhosis development in patients with nonalcoholic steatohepatitis (NASH). The association between diabetes and the risk of hepatocellular carcinoma (HCC) in NASH...